These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17182616)

  • 1. Modulation of DRAK2 autophosphorylation by antigen receptor signaling in primary lymphocytes.
    Friedrich ML; Cui M; Hernandez JB; Weist BM; Andersen HM; Zhang X; Huang L; Walsh CM
    J Biol Chem; 2007 Feb; 282(7):4573-4584. PubMed ID: 17182616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase D orchestrates the activation of DRAK2 in response to TCR-induced Ca2+ influx and mitochondrial reactive oxygen generation.
    Newton RH; Leverrier S; Srikanth S; Gwack Y; Cahalan MD; Walsh CM
    J Immunol; 2011 Jan; 186(2):940-50. PubMed ID: 21148796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DRAK2, a lymphoid-enriched DAP kinase, regulates the TCR activation threshold during thymocyte selection.
    Friedrich ML; Wen BG; Bain G; Kee BL; Katayama C; Murre C; Hedrick SM; Walsh CM
    Int Immunol; 2005 Nov; 17(11):1379-90. PubMed ID: 16172133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A deficiency in Drak2 results in a T cell hypersensitivity and an unexpected resistance to autoimmunity.
    McGargill MA; Wen BG; Walsh CM; Hedrick SM
    Immunity; 2004 Dec; 21(6):781-91. PubMed ID: 15589167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced T cell apoptosis within Drak2-deficient mice promotes resistance to autoimmunity.
    Ramos SJ; Hernandez JB; Gatzka M; Walsh CM
    J Immunol; 2008 Dec; 181(11):7606-16. PubMed ID: 19017949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drak2 regulates the survival of activated T cells and is required for organ-specific autoimmune disease.
    McGargill MA; Choy C; Wen BG; Hedrick SM
    J Immunol; 2008 Dec; 181(11):7593-605. PubMed ID: 19017948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.
    Arnold R; Patzak IM; Neuhaus B; Vancauwenbergh S; Veillette A; Van Lint J; Kiefer F
    Mol Cell Biol; 2005 Mar; 25(6):2364-83. PubMed ID: 15743830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for DRAK2 in the germinal center reaction and the antibody response.
    Al-Qahtani A; Xu Z; Zan H; Walsh CM; Casali P
    Autoimmunity; 2008 Aug; 41(5):341-52. PubMed ID: 18568639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drak2 Does Not Regulate TGF-β Signaling in T Cells.
    Harris TL; McGargill MA
    PLoS One; 2015; 10(5):e0123650. PubMed ID: 25951457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filamin A Phosphorylation at Serine 2152 by the Serine/Threonine Kinase Ndr2 Controls TCR-Induced LFA-1 Activation in T Cells.
    Waldt N; Seifert A; Demiray YE; Devroe E; Turk BE; Reichardt P; Mix C; Reinhold A; Freund C; Müller AJ; Schraven B; Stork O; Kliche S
    Front Immunol; 2018; 9():2852. PubMed ID: 30568657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apoptosis-inducing protein kinase DRAK2 is inhibited in a calcium-dependent manner by the calcium-binding protein CHP.
    Kuwahara H; Kamei J; Nakamura N; Matsumoto M; Inoue H; Kanazawa H
    J Biochem; 2003 Aug; 134(2):245-50. PubMed ID: 12966074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, in human T lymphocytes. Regulation of kinase activity by T cell receptor signaling.
    Hanissian SH; Frangakis M; Bland MM; Jawahar S; Chatila TA
    J Biol Chem; 1993 Sep; 268(27):20055-63. PubMed ID: 8397199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRAK2 regulates memory T cell responses following murine coronavirus infection.
    Schaumburg CS; Gatzka M; Walsh CM; Lane TE
    Autoimmunity; 2007 Nov; 40(7):483-8. PubMed ID: 17966037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell activation up-regulates the expression of the focal adhesion kinase Pyk2: opposing roles for the activation of protein kinase C and the increase in intracellular Ca2+.
    Tsuchida M; Manthei ER; Alam T; Knechtle SJ; Hamawy MM
    J Immunol; 1999 Dec; 163(12):6640-50. PubMed ID: 10586059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.
    Hutchcroft JE; Slavik JM; Lin H; Watanabe T; Bierer BE
    J Immunol; 1998 Nov; 161(9):4506-12. PubMed ID: 9794375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system.
    Ramos SJ; Hardison JL; Stiles LN; Lane TE; Walsh CM
    Autoimmunity; 2007 Feb; 40(1):54-65. PubMed ID: 17364498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
    Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
    J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.
    Lee KY; D'Acquisto F; Hayden MS; Shim JH; Ghosh S
    Science; 2005 Apr; 308(5718):114-8. PubMed ID: 15802604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization signal and phosphorylation of Serine350 specify intracellular localization of DRAK2.
    Kuwahara H; Nishizaki M; Kanazawa H
    J Biochem; 2008 Mar; 143(3):349-58. PubMed ID: 18084041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia.
    Szoltysek K; Ciardullo C; Zhou P; Walaszczyk A; Willmore E; Rand V; Marshall S; Hall A; J Harrison C; Eswaran J; Soundararajan M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.